RIW worked with Hywel Dda University Health Board and the device manufacturer, CR Clarke Ltd, to design, arrange, manage and report the clinical trial of a COVID-19 rapid manufacturing challenge CPAP device, the CTEX WG7. RIW took the study application through the expedited COVID-19 research permissions and ethics processes and liaised with the MHRA throughout the process.

RIW took the study application through the expedited COVID-19 research permissions and ethics processes and liaised with the MHRA throughout the process. RIW’s End of Study report has been accepted by the MHRA and the manufacturer commended RIW for its efforts to complete this study.

Original Ethics approval: COVID-19 CPAP VENTILATOR: CTEX-WG5 v01 (Current Device: CTEX WG7) [COVID-19] – Health Research Authority (hra.nhs.uk)

Publication(s): Paper in early stage preparation for BMJ Innovations